For example, care technology company WellSky is careful to make sure it’s “keeping a human in the loop and not developing any ...

Trump's canceled NIH grants and HHS layoffs threaten U.S. biomedical leadership, Collins says, as she calls for funding to be ...

Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate ...

Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

NIH has cancelled its participation in Safe to Sleep, a 30-year campaign to prevent babies from dying in their sleep ...

Lack of clarity from officials delay providers' efforts to ensure clinical decision support tools don't discriminate.

Twenty years after the debates of the George W. Bush era, there appears to be a serious threat that all government human ...

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

As medical schools struggle to source cadavers ethically and affordably, many are turning to technology instead. That, one ...